← Back to ZYME

Zymeworks Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
$4.6$2.4$28$49$27$16$19$10
−$45−$44−$20$2.3−$23−$30−$38−$32
−$0.62−$0.59−$0.26$0.03−$0.30−$0.39−$0.49−$0.42
7375767775767676

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.